Dose Level 2 (starting dose) clinical trials

Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer

This study looks at combining two drugs, Idetrexed and olaparib, to treat a type of ovarian cancer (high-grade serous) that hasn't responded to usual treatments. The goal is to see if this combination can target cancer cells more effectively.